Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Pharmacological blockade of the WNT-beta-catenin signaling: a possible first-in-kind DMOAD.
QMRO Home
William Harvey Research Institute
Centre for Experimental Medicine and Rheumatology (EMR)
Pharmacological blockade of the WNT-beta-catenin signaling: a possible first-in-kind DMOAD.
QMRO Home
William Harvey Research Institute
Centre for Experimental Medicine and Rheumatology (EMR)
Pharmacological blockade of the WNT-beta-catenin signaling: a possible first-in-kind DMOAD.
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Pharmacological blockade of the WNT-beta-catenin signaling: a possible first-in-kind DMOAD.
View/
Open
Accepted version (487.0Kb)
Volume
26
Pagination
4 - 6
DOI
10.1016/j.joca.2017.10.014
Journal
Osteoarthritis Cartilage
Issue
1
Metadata
Show full item record
Authors
Dell'Accio, F; Cailotto, F
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/31328
Collections
Centre for Experimental Medicine and Rheumatology (EMR)
[471]
Language
eng
Licence information
© 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright statements
© 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.